Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

    Diabetes Care Date published:

  • Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review

    Public Health Reviews Date published:

  • The effects on clinical trial activity of direct funding and taxation policy interventions made by government: A systematic review

    PLOS ONE Date published:

  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Effect of voluntary Health Star Rating labels on healthier food purchasing in New Zealand: longitudinal evidence using representative household purchase data

    BMJ Nutrition, Prevention & Health Date published:

  • Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

    Journal of the American Heart Association Date published:

  • Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis

    Heart Date published:

  • The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review

    Humanities and Social Sciences Communications Date published:

  • Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)

    Diabetes Care Date published:

  • The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

    Diabetes & Metabolism Date published:

  • Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE

    International Journal of Cardiology Date published:

  • Mechanisms of action of the sodium-glucose cotransporter-2 ( SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial

    Diabetes, Obesity and Metabolism Date published:

  • Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • 19-OR: KidneyIntelX Association with Clinical Outcomes in Diabetic Kidney Disease

    Diabetes Date published:

  • Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study

    Circulation Date published:

  • 2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

    Journal of Human Hypertension Date published: